Drug Type Small molecule drug |
Synonyms MDA 39, MDA39 |
Target |
Mechanism CB2 agonists(Cannabinoid CB2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H24ClNO2 |
InChIKeyBAXHQVTWHKSLQH-UHFFFAOYSA-N |
CAS Registry1104641-35-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | US | 01 Oct 2009 |